ZFP108 inhibitors are a class of chemical compounds specifically designed to target zinc finger protein 108 (ZFP108), a transcription factor involved in regulating gene expression through its interaction with DNA. ZFP108 contains zinc finger motifs, structural domains that allow the protein to bind to specific DNA sequences and regulate the transcription of certain genes. These zinc finger motifs are stabilized by zinc ions, which are essential for maintaining the proper conformation of the protein and enabling its function. ZFP108's ability to recognize and bind to target DNA sequences is critical for its role in controlling gene transcription, which in turn affects various cellular processes. Inhibitors of ZFP108 function by disrupting this DNA-binding activity, either by destabilizing the zinc finger motifs or by directly preventing the protein from interacting with its target DNA sequences, leading to changes in gene regulation.
The mechanisms by which ZFP108 inhibitors operate can vary, but a common approach involves chelating the zinc ions that are necessary for maintaining the structural integrity of the zinc finger domains. By binding to these zinc ions, the inhibitors cause the zinc finger motifs to lose their proper conformation, which prevents ZFP108 from binding to DNA effectively. Without this interaction, ZFP108's regulatory function is impaired, and the transcription of genes under its control is altered. Another mechanism by which ZFP108 inhibitors may act is by blocking critical protein-protein interactions required for ZFP108's role in forming transcriptional complexes. By disrupting these interactions, the inhibitors can further impair ZFP108's ability to regulate gene expression. Research into ZFP108 inhibitors provides insights into the broader mechanisms of zinc finger proteins and their role in gene expression, offering a deeper understanding of how transcription factors influence complex genetic networks and cellular functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D inhibits ZNF108 expression by intercalating into DNA, preventing the transcription of ZNF108-regulated genes, thereby reducing its expression levels. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits ZNF108 expression by blocking protein synthesis, leading to reduced levels of newly synthesized ZNF108 and impacting its regulatory functions. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Puromycin inhibits ZNF108 expression by causing premature chain termination during protein synthesis, leading to reduced levels of functional ZNF108 protein. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin inhibits ZNF108 expression by intercalating into DNA, disrupting the transcription of ZNF108-regulated genes, leading to decreased ZNF108 expression. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin inhibits ZNF108 expression by forming DNA adducts, interfering with the binding of transcription factors to ZNF108-regulated genes, thus reducing its expression. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-Fluorouracil inhibits ZNF108 expression by interfering with DNA synthesis, disrupting the transcription of ZNF108-regulated genes, leading to reduced ZNF108 expression. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin inhibits ZNF108 expression by stabilizing the cleavable complex formed by topoisomerase I, leading to DNA damage and reduced ZNF108 expression. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Mitomycin C inhibits ZNF108 expression by forming DNA adducts, interfering with the binding of transcription factors to ZNF108-regulated genes, thus reducing its expression. | ||||||
Bleomycin | 11056-06-7 | sc-507293 | 5 mg | $275.00 | 5 | |
Bleomycin inhibits ZNF108 expression by causing DNA strand breaks and oxidative damage, leading to reduced ZNF108 expression. | ||||||
Idarubicin | 58957-92-9 | sc-507346 | 10 mg | $180.00 | ||
Idarubicin inhibits ZNF108 expression by intercalating into DNA, disrupting the transcription of ZNF108-regulated genes, leading to decreased ZNF108 expression. | ||||||